NRx Pharmaceuticals Inc.

NASDAQ: NRXP · Real-Time Price · USD
2.88
0.21 (7.87%)
At close: Aug 15, 2025, 3:59 PM
2.87
-0.34%
After-hours: Aug 15, 2025, 07:40 PM EDT

NRx Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
5K 5K 4K 2K
Gross Profit
n/a -5K -4K -2K
Operating Income
-18.5M -27.59M -44.34M -115.8M
Interest Income
44K 494K 249K 18.00
Pretax Income
-25.13M -30.16M -39.75M -93.06M
Net Income
-25.13M -30.15M -39.75M -93.06M
Selling & General & Admin
13.51M 14.21M 27.37M 74.94M
Research & Development
6.2M 13.37M 17.03M 20.26M
Other Expenses
n/a 250K n/a -771K
Operating Expenses
19.7M 27.58M 44.4M 94.43M
Interest Expense
230K 120K n/a 18K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
19.7M 27.59M 44.4M 94.43M
Income Tax Expense
n/a -9K n/a n/a
Shares Outstanding (Basic)
10.52M 7.58M 65.77M 46.92M
Shares Outstanding (Diluted)
10.52M 7.58M 65.77M 46.92M
EPS (Basic)
-2.39 -3.98 -0.6 -7.44
EPS (Diluted)
-2.39 -3.98 -0.6 -7.44
EBITDA
-18.5M -30.02M -39.75M -93.04M
EBIT
-24.9M -30.03M -39.75M -93.05M
Depreciation & Amortization
5K 5K 4K 2K